Description
The VA is issuing an unrestricted, firm‑fixed‑price IDIQ contract to provide Cepheid GeneXpert diagnostic testing supplies for six VA medical facilities across West Virginia, Maryland, and the District of Columbia. The contract will be awarded to a single vendor for a base year with four optional renewal years, with delivery orders placed as funds become available. This opportunity is suited for companies that can manufacture or distribute in‑vitro diagnostic cartridges and have existing SAM registration.
• Primary product: Cepheid GeneXpert testing cartridges/reagents (NAICS 325413).
• Scope: Supply to six VA sites (Beckley, Clarksburg, Huntington, Martinsburg, Baltimore, Washington, DC).
• Contract structure: IDIQ, base year + four options, firm‑fixed‑price delivery orders.
• Deadline: Proposals due 16 Nov 2026, 10 AM ET; formal solicitation expected 7 Oct 2026 on SAM.gov.
• Required: Vendor must be registered in SAM; no set‑aside restrictions.